These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 197543)

  • 1. Cyclic nucleotide phosphodiesterase activity in cardiac and vascular smooth muscle of the spontaneously hypertensive rat.
    Taylor JE; Shirachi DY
    Proc West Pharmacol Soc; 1977; 20():307-10. PubMed ID: 197543
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of aortic and cardiac cyclic AMP phosphodiesterase during the onset of mineralpcorticoid hypertension in the rat [proceedings].
    Lugnier C; Michon T; Stoclet JC
    Br J Pharmacol; 1976 Nov; 58(3):434P-435P. PubMed ID: 186145
    [No Abstract]   [Full Text] [Related]  

  • 3. Age related changes in cardiac and aortic phosphodiesterase activities in normotensive and hypertensive rats.
    Lugnier C; Stoclet JC
    Biochem Pharmacol; 1979 Dec; 28(24):3581-7. PubMed ID: 231449
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of altered cyclic nucleotide phosphodiesterase activity in the aorta and heart of the spontaneously hypertensive rat.
    Donnelly TE
    Biochim Biophys Acta; 1978 Aug; 542(2):245-52. PubMed ID: 210834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and regulation of the phosphodiesterases of muscle tissues.
    Gain KR; Appleman MM
    Adv Cyclic Nucleotide Res; 1978; 9():221-31. PubMed ID: 208376
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart.
    Lehotay DC; Levey GS; Vesely DL; Bornet EP; Ray MV; Entman ML; Schwartz A
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):55-65. PubMed ID: 14979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of thyroxine on the contents of cyclic AMP and on the activity of cyclic AMP phosphodiesterase in hepatocytes of the rat].
    Leoni S; Spagnuolo S
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1874-8. PubMed ID: 182190
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 14. The activity of adenylate cyclase and phosphodiesterase in the isoproterenol-damaged cardiac muscle of spontaneously hypertensive rats.
    Piekarska T
    Pol J Pharmacol Pharm; 1983; 35(2):109-14. PubMed ID: 6312439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
    Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
    Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation effects on the activity of 3',5'-cyclic-AMP phosphodiesterase in isolated rat thymocytes].
    Zhivotova NI; Filippovich IV; Romantsev EF
    Dokl Akad Nauk SSSR; 1975 May; 222(3):736-9. PubMed ID: 165926
    [No Abstract]   [Full Text] [Related]  

  • 17. Rat pineal adenosine cyclic 3',5'-monophosphate phosphodiesterase activity: modulation in vivo by a beta adrenergic receptor.
    Oleshansky MA; Neff NH
    Mol Pharmacol; 1975 Sep; 11(5):552-7. PubMed ID: 170502
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of drugs stimulating dopaminergic system on phosphodiesterase activity in rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1976; 28(6):631-4. PubMed ID: 189292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide phosphodiesterase in silkworm. Developmental change of cyclic AMP and cyclic GMP phosphodiesterases.
    Morishima I
    Biochim Biophys Acta; 1975 Sep; 403(1):106-12. PubMed ID: 240422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGMP signal termination.
    Pyne NJ; Arshavsky V; Lochhead A
    Biochem Soc Trans; 1996 Nov; 24(4):1019-22. PubMed ID: 8968504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.